Amitriptyline: linear or nonlinear kinetics in every day practice?

Alexanderson B (1972) Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses. A crossover study. Eur J Clin Pharmacol 5: 1–10

American Psychiatric Association (1985) Tricyclic antidepressants — blood level measurements and clinical outcome: An APA task force report. Task force on the use of laboratory test in psychiatry. Am J Psychiatry 142: 155–162

Amsterdam J, Brunswick D, Mendels J (1980) The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am J Psychiatry 137: 653–662

Asberg N, Cronholm B, Sjöqvist F, Tuck D (1971) Relationship between plasma level and therapeutic effect of nortriptyline. Br Med J 3: 331–334

Bjerre M, Gram LF, Kragh-Sorensen P, Pedersen OL (1981) Dose dependent kinetics of imipramine in elderly patients. Psychopharmacology 75: 354–357

Breyer-Pfaff U, Gaetner HJ, Giedke H (1982) Plasma levels, psychophysiological variables and clinical response to amitriptyline. Psychiatry Res 6: 223–234

Burch JE, Hullin RP (1981) Amitriptyline pharmacokinetics. A crossover study with single doses of amitriptyline and nortriptyline. Psychopharmacology 74: 35–42

Cooke RG, Warsh JJ, Stancer HC, Reed KL, Persad E (1984) The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma. Clin Pharmacol Ther 36: 343–349

Derenne F, Joanne C, Vandel S, Bertschy G, Volmat R (1989) Debrisoquine oxidation phenotyping and psychiatric treatment. Eur J Clin Pharmacol 36: 53–58

Dugas JE, Bishop DS (1985) Non-linear desipramine pharmacokinetics: a case study. J Clin Psychopharmacol 5: 43–45

Gram LF, Bjerre M, Kragh-Sorensen P, Kuinesdal B, Molin J, Pedersen OL, Reisby N (1983) Imipramine metabolites in blood of patients during therapy and after overdose. Clin Pharmacol Ther 33: 335–342

Gram LF, Debruyne D, Caillard V, Boulenger JP, Lacotte J, Moulin M, Zarifian E (1989) Substantial rise in sparteine metabolic ratio during haloperidol treatment. Br J Clin Pharmacol 27: 272–275

Gram LF, Kragh-Sorensen P (1981) Pharmacokinetics and plasma level/effect relationships of tricyclic antidepressants. An update. In: Usdin E, Dahl E, Gram LF, Lingjaercle O (eds) Clinical pharmacology in psychiatry: Neuroleptic and antidepressant research. MacMillan, London, pp 241–252

Mellström B, Bertilsson L, Säwe J, Schultz HU, Sjöqvist F (1981) E and Z-10 hydroxylation of nortriptyline relationship to polymorphic debrisoquine hydroxylation. Clin Pharmacol Ther 30: 189–193

Mellström B, Bertilsson L, Träskman L, Rollins D, Asberg M, Sjöqvist P (1979) Intraindividual similarity in the metabolism of amitriptyline and chlorimipramine in depressed patients. Pharmacology 19: 282–287

Montgomery SA, McAuley R, Rani SJ, Montgomery DB, Braithwaite RA, Dawling S (1979) Amitriptyline plasma concentration and clinical response. Br Med J 1: 230–231

Nelson JC, Jatlow PI (1987) Non-linear desipramine kinetics: prevalence and importance. Clin Pharmacol Ther 41: 666–670

Preskorn SH, Dorey RC, Jerkovick GS (1988) Therapeutic monitoring of tricyclic antidepressants. Clin Chem 34: 822–828

Rollins DE, Alvan G, Bertilsson L, Gillette JR, Mellström B, Sjöqvist F, Träskman L (1980) Interindividual differences in amitriptyline demethylation. Clin Pharmacol Ther 28: 121–129

Vandel S, Sandoz M, Vandel B, Bonin B, Allers G, Volmat R (1986) Biotransformation of amitriptyline in man: Interaction with phenothiazines. Neuropsychobiology 15: 15–19

Vandel S, Vandel B, Sandoz M, Allers G, Bechtel P, Volmat R (1978) Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline. Eur J Clin Pharmacol 14: 185–190

Vandel B, Vandel S, Jounet JM, Allers G, Volmat R (1982) Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response. Eur J Clin Pharmacol 22: 15–20

Ziegler VE, Clayton PJ, Biggs JT (1977) A comparison study of amitriptyline and nortriptyline with plasma levels. Arch Gen Psychiatry 34: 607–612